Skip to main content
← Longevity

Whole-genome sequencing

Inside my genome

I analyzed my whole-genome sequencing results to explore the biology behind longevity, cardiovascular health, and performance. These are selected research findings that caught my attention.

Analysis completed July 24, 2026 · GRCh38 reference · analysis v0.4.0

A research lens on longevity

The standout is a FOXO3 marker pattern associated with longevity in several cohort studies. Genetic associations describe patterns in populations; they do not predict how long I will live or establish which intervention works for me.

Longevity

FOXO3 longevity association

The queried FOXO3 marker showed a pattern associated with longevity in multiple cohort studies.

Call confidence: high for the queried marker

  • This is a modest population-level association with no validated personal intervention.
  • Effects vary by ancestry, sex, cohort, and study design.
Research source 1 ↗Research source 2 ↗

Longevity

APOE longevity context

The APOE result falls in the common neutral-reference category used in this research summary.

Call confidence: provisional; some reference evidence is inferred

  • APOE is a susceptibility marker, not a diagnosis or lifespan forecast.
  • The same allele can relate differently to longevity, lipid biology, and disease risk.
Research source 1 ↗Research source 2 ↗

Cardiometabolic

Lipoprotein(a) genetic context

Neither of the two queried common LPA risk alleles was detected.

Call confidence: provisional; some reference evidence is inferred

  • These two markers do not capture LPA KIV-2 copy number or all ancestry-specific variation.
  • Only a blood Lp(a) measurement can establish the biomarker level.
Research source 1 ↗Research source 2 ↗

Exploratory

KL-VS research marker

The queried KL-VS component pattern was not identified.

Call confidence: provisional; some reference evidence is inferred

  • KL-VS findings are mixed across cohorts and are not clinically actionable.
  • The haplotype requires both component alleles on the same chromosome.
Research source 1 ↗

Lifestyle

Caffeine response genetics

The panel combines a CYP1A2 inducibility marker, an AHR coffee-consumption marker, and an ADORA2A sensitivity marker; it does not support a categorical fast/slow label.

Call confidence: high for the queried marker

  • Smoking, medications, hormones, dose, habitual intake, and sleep timing can dominate these associations.
  • The result is not permission for high-dose or late-day caffeine.
Research source 1 ↗Research source 2 ↗Research source 3 ↗

Performance

ACTN3 muscle-performance context

The ACTN3 result is consistent with alpha-actinin-3 expression, a common category with at most modest population-level power/sprint associations.

Call confidence: provisional; some reference evidence is inferred

  • This marker cannot predict talent, training response, or sport suitability.
  • Training, physiology, health, opportunity, and many other genes dominate individual performance.
Research source 1 ↗Research source 2 ↗

How I interpret these findings

This summary uses a curated panel matched against my Sequencing.com callset. High call confidence refers to the genetic observation, not the size of a health benefit. Provisional findings can rely on covered reference evidence rather than an explicit site-level call. Effects vary across populations, and this panel is not a comprehensive clinical genetic assessment.

Research and educational context only. These associations do not diagnose disease, predict lifespan, or replace clinical testing. My raw genome, individual genotypes, and clinical screening candidates remain private.

See my measured TruAge results and full test history →